Drug Profile
AIP 201
Alternative Names: MyoMap; Quantison DepotLatest Information Update: 17 Sep 2007
Price :
$50
*
At a glance
- Originator Innovata
- Class Contrast media
- Mechanism of Action Ultrasonography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiomyopathies
Most Recent Events
- 19 Jan 2007 Innovata has been acquired by Vectura
- 05 Nov 2003 Preclinical trials in Cardiomyopathy (diagnosis) in United Kingdom (Intra-arterial)
- 30 Mar 2001 Quadrant Healthcare has been acquired by Elan Corporation